Bianca Van Broeck

发表

Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ-54861911, a potent oral BACE inhibitor

Vikash K. Sinha, E. Liu, L. Shaw, 2016, Alzheimer's & dementia.

Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-β Isoforms for Early and Differential Dementia Diagnosis.

H. Struyfs, K. Sleegers, C. van Broeckhoven, 2015, Journal of Alzheimer's disease : JAD.

Mean age‐of‐onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Aβ42 and decreased Aβ40

C. van Broeckhoven, M. Cruts, J. Theuns, 2006, Human mutation.

Current Insights into Molecular Mechanisms of Alzheimer Disease and Their Implications for Therapeutic Approaches

C. van Broeckhoven, S. Kumar-Singh, B. Van Broeck, 2007, Neurodegenerative Diseases.

Mass spectrometric characterization of intact desferal-conjugated monoclonal antibodies for immuno-PET imaging.

M. Mercken, D. Pemberton, B. Van Broeck, 2018, Rapid communications in mass spectrometry : RCM.

Synthesis and Evaluation of a Zr-89-Labeled Monoclonal Antibody for Immuno-PET Imaging of Amyloid-β Deposition in the Brain

S. Dedeurwaerdere, M. Mercken, S. Stroobants, 2016, Molecular Imaging and Biology.

Diffusion kurtosis imaging allows the early detection and longitudinal follow-up of amyloid-β-induced pathology

Mark E. Schmidt, D. Smeets, J. Sijbers, 2018, Alzheimer's Research & Therapy.

Impact of frequent cerebrospinal fluid sampling on Aβ levels: systematic approach to elucidate influencing factors

L. Shaw, S. Engelborghs, J. Streffer, 2016, Alzheimer's Research & Therapy.

Anti-tau intrabodies: From anti-tau immunoglobulins to the development of functional scFv intrabodies

K. Van Kolen, Bianca Van Broeck, M. Mercken, 2023, Molecular Therapy. Methods & Clinical Development.

Neural oscillations during cognitive processes in an App knock-in mouse model of Alzheimer’s disease pathology

D. Balschun, W. Drinkenburg, M. De Bock, 2019, Scientific Reports.